Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis
|更新时间:2024-01-04
|
Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 1, Pages: 300-303(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
HAN Li-hua, XU Hui-mei, ZHOU Duan, et al. Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(1): 300-303.
DOI:
HAN Li-hua, XU Hui-mei, ZHOU Duan, et al. Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(1): 300-303.DOI:
Xinjikang Program in Ntreatment of Syndrome of Acute Phase of Viral Yyocarditis
Objective: To explore the impact of Xinjikang program on syndrome of the acute phase of viral myocarditis. Method: One hundred and sixty-one cases from Henan Chinese medical hospital
Heilongjiang Academy of traditional Chinese medicine(TCM)
Shanghai University of TCM
Longhua Hospital three hospital
entered the study. Cases were randomly divided into treatment group and control group. The treatment group was treated by Xinjikang program plus basic treatment
control group was treated by conventional western medicine plus the basic measures. The course lasted for 30 days. The patient's syndromes were observed. Result: The difference of syndrome total score between the two groups was statistically significant (P<0.05). The difference of total score syndrome at various time point between the two groupswas statistically significant (P<0.05). The difference of total score syndrome before and after treatment was statistically significant (P<0.05). Conclusion: Xinjikang program and routine western medicine can improve the syndromes in patients with syndrome of the acute phase of viral myocarditis but efficiency of Xinjikang program was significantly superior to conventional western treatment.
International Clinical Practice Guideline of Traditional Chinese Medicine ‧ Viral Myocarditis
Anti-oxidation and Anti-inflammatory Effect of Yixinshu Capsule in Treatment of Qi-Yin Deficiency in Viral Myocarditis
Clinical Efficacy and Experiences of Lung-toxin Dispelling Formula No.1 Treating Patients of Corona Virus Disease 2019 Type Severe/type Extremely Severe
Clinical Efficacy of Shensuyin in Treating Adult Viral Myocarditis with Syndrome of Insufficiency of Lung-Qi
Optimization of Anti-coxsackie B Complex Capsule for Treating Myocarditis Induced by Coxsackie B Virus and Anti-stress Effect of Capsule
Related Author
Xue-mei YANG
Qing-yan YANG
Chen WANG
Ren-dong LI
Xue-bing LIU
Pei-du JIANG
Related Institution
Sichuan Academy of Medical Sciences, Sichuan People's Hospital
Chengdu Fifth People's Hospital Chengdu
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Central Hospital in Zhumadian
World Health Science Organization, Virginia Leesburg